Schaufelberger Maria, Swedberg Karl, Köster Max, Rosén Måns, Rosengren Annika
Department of Medicine, Sahlgrenska University Hospital/Ostra, Göteborg, Sweden.
Eur Heart J. 2004 Feb;25(4):300-7. doi: 10.1016/j.ehj.2003.12.012.
To investigate if improved treatment of coronary heart disease and hypertension, the major causes of chronic heart failure (CHF), in the last 20 years has had an impact on the incidence of CHF and survival.
National Swedish registers on hospital discharges and cause-specific deaths were used to calculate age- and sex-specific trends and sex ratios for heart failure admissions and deaths. The study included all men and women 45 to 84 years old hospitalized for the first time for heart failure in 19 Swedish counties between 1988 and 2000, a mean annual population 2.9 million. A total of 156?919 hospital discharges were included.
In 1988, a total of 267 men and 205 women per 100?000 inhabitants (age adjusted) were discharged for the first time with a principal diagnosis of heart failure. After 1993 a yearly decrease was observed, with 237 men and 171 women per 100?000 inhabitants discharged during 2000. The 30-day mortality decreased significantly. The decrease in 1-year mortality was more pronounced in the younger age groups, with a total reduction in mortality of 69% among men and 80% among women aged 45-54 years. The annual decrease was 9% among men and 10% among women aged 45-54 years (95% CI -7% to -12% and -6% to -14% respectively) and 4% among men and 5% among women (95% CI -4% to -5% for both) aged 75-84 years.
The decrease in incidence and improved prognosis after a first hospitalization for heart failure coincides with the establishment of ACE-inhibitor therapy, the introduction of beta-blockers for treatment of heart failure, home-care programmes for heart failure, and more effective treatment and prevention of underlying diseases. Notwithstanding, despite considerable improvement, 1-year mortality after a first hospitalization for heart failure is still high.
调查过去20年中,作为慢性心力衰竭(CHF)主要病因的冠心病和高血压治疗的改善是否对CHF的发病率和生存率产生了影响。
利用瑞典国家医院出院登记和特定病因死亡登记来计算心力衰竭入院和死亡的年龄及性别特异性趋势以及性别比。该研究纳入了1988年至2000年期间在瑞典19个县首次因心力衰竭住院的所有45至84岁的男性和女性,年均人口为290万。共纳入156919例医院出院病例。
1988年,每10万居民(年龄调整后)中首次因心力衰竭主要诊断出院的男性有267人,女性有205人。1993年后观察到每年下降,2000年每10万居民中出院的男性有237人,女性有171人。30天死亡率显著下降。1年死亡率的下降在较年轻年龄组中更为明显,45至54岁男性的死亡率总体下降69%,女性下降80%。45至54岁男性的年下降率为9%,女性为10%(95%可信区间分别为-7%至-12%和-6%至-14%),75至84岁男性的年下降率为4%,女性为5%(两者95%可信区间均为-4%至-5%)。
首次因心力衰竭住院后发病率的下降和预后的改善与ACE抑制剂治疗的建立、β受体阻滞剂用于心力衰竭治疗、心力衰竭家庭护理计划以及基础疾病更有效的治疗和预防相吻合。尽管如此,尽管有相当大的改善,但首次因心力衰竭住院后的1年死亡率仍然很高。